Legato Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Legato Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.27M	Sell	74,128 -6,842	-8%	-$393K	0.35%	56
2026 Q1	$4.91M	Sell	80,970 -18,614	-19%	-$1.09M	0.45%	32
2025 Q4	$5.37M	Buy	99,584 +57,438	+136%	+$2.76M	0.46%	29
2025 Q3	$1.9M	Hold	42,146	–	–	0.21%	145
2025 Q2	$1.95M	Hold	42,146	–	–	0.23%	120
2025 Q1	$2.57M	Hold	42,146	–	–	0.35%	69
2024 Q4	$2.38M	Hold	42,146	–	–	0.31%	75
2024 Q3	$2.18M	Buy	42,146 +5,889	+16%	+$276K	0.27%	106
2024 Q2	$1.51M	Sell	36,257 -16,614	-31%	-$743K	0.2%	177
2024 Q1	$2.87M	Buy	52,871 +9,298	+21%	+$474K	0.35%	70
2023 Q4	$2.24M	Hold	43,573	–	–	0.29%	97
2023 Q3	$2.53M	Hold	43,573	–	–	0.37%	56
2023 Q2	$2.79M	Buy	43,573 +6,568	+18%	+$440K	0.38%	59
2023 Q1	$2.56M	Buy	37,005 +4,751	+15%	+$335K	0.47%	39
2022 Q4	$2.32M	Buy	+32,254	New	+$2.43M	0.44%	42

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Legato Capital Management's BMY Position: Q2 2026 in Review

Legato Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 8.5% in Q2 2026, selling an estimated $393K and leaving 74,128 shares worth $4.27M. The position accounts for 0.35% of the portfolio, ranked #56.

Legato Capital Management first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.37M in Q4 2025. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Legato Capital Management held 74,128 shares of Bristol-Myers Squibb worth $4.27M as of Q2 2026.
Legato Capital Management sold 6,842 Bristol-Myers Squibb shares in Q2 2026, an estimated $393K.
Bristol-Myers Squibb made up 0.35% of Legato Capital Management's portfolio in Q2 2026, its #56 holding.
Legato Capital Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
Legato Capital Management's Bristol-Myers Squibb position peaked at $5.37M in Q4 2025.
2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.